[ASAP] New Triazacycloalkane Derivatives as Cytotoxic Agents for CLL Treatment: From Proof of Concept to the Targeting Biomolecule

Bioconjugate ChemistryDOI: 10.1021/acs.bioconjchem.2c00227

Source: Bioconjugate Chemistry - June 16, 2022 Category: Biochemistry Authors: Axia Marlin, Fiona Le Pape, Jocelyn Le Goff, Nade ̀ge Hamon, Thibault Troadec, Raphaël Tripier, Christian Berthou, and Véronique Patinec Source Type: research